Beranda › Alopecia Areata › Florida
Uji klinis Alopecia Areata di Florida
8 studi untuk Alopecia Areata mencari peserta di lokasi di Florida.
Kota di Florida
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Pediatric Skin Research - Miami /ID# 283281, Miami
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Health Clinical Research, LLC, Cutler Bay
Menerima pesertaFase 2
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Pediatric Skin Research, Miami
- Skin Research of South Florida, Miami
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06873945HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
- James A. Haley Veterans' Hospital, Tampa
Menerima pesertaFase 1
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07049328A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Skin Research of South Florida, Miami
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Skin Care Research Boca Raton /ID# 258012, Boca Raton
- Skin Care Research - Hollywood /ID# 259210, Hollywood
- GSI Clinical Research, LLC /ID# 259352, Margate
- dan 2 lainnya
Menerima pesertaFase 3
Usia 12 hingga 63 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06012240A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Pediatric Skin Research, Miami
- D&H Tamarac Research Center, Tamarac
Menerima pesertaFase 3
Usia 6 hingga 14 · Semua jenis kelamin · Diperbarui 28 Apr 2026 · NCT07029828Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- D&H Doral Research Center, Doral
- Skin Care Research, Llc - Hollywood, Hollywood
- Ilumina Medical Research Llc, Kissimmee
- dan 12 lainnya
Menerima pesertaFase 3
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 28 Jan 2026 · NCT07133308Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.